Drug research

Tafenoquine

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Trial	Sponsor	Phase	Status	Primary completion
Oral Tafenoquine Plus Standard of Care Versus Placebo Plus Standard of Care for BabesiosisNCT06207370	60 Degrees Pharmaceuticals LLC	Phase 2	Recruiting	2027-03-01Estimated
Long-Term Safety Study of TafenoquineNCT03320174	60 Degrees Pharmaceuticals LLC	Phase 2	Completed	2021-07-13Actual

60 Degrees Pharmaceuticals LLCRecruitingPrimary completion: 2027-03-01 · Estimated

Trial details

60 Degrees Pharmaceuticals LLCCompletedPrimary completion: 2021-07-13 · Actual

Trial details

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.